Tarkieltaub E
Hospital Municipal Prof Dr Alípio Correa Neto, São Paulo.
Arq Bras Cardiol. 1995 Apr;64(4):345-6.
The lack of facilities sometime blocks the use of thrombolytic therapy in public hospitals. In this report, initial experience with the use of thrombolytics in a Municipal Hospital located in São Paulo suburb area, which has no hemodynamic laboratory available, is reported. Prospectively, 45 patients admitted to the adult medicine care unit with acute myocardial infarction from Dec/93 to May/94 were evaluated. Twenty four patients were submitted to thrombolytic therapy by streptokinase (SK), 1.500.00 units IV in the peripheral vein. They showed the following signs of reperfusion: relief of pain, rapid resolution of ST-segment elevation, reperfusion associated arrhythmias and early enzymatic peak (CK-MB). Seven deaths were recorded, six of them did not receive SK. The use of thrombolytic, even in hospitals without haemodynamic laboratory, has contributed to the decrease of mortality. Thus, this therapy should be used as early as possible in acute myocardial infarction.
有时,设备的缺乏阻碍了公立医院溶栓治疗的使用。在本报告中,报道了在圣保罗郊区一家没有血流动力学实验室的市立医院使用溶栓剂的初步经验。前瞻性地评估了1993年12月至1994年5月期间入住成人内科护理单元的45例急性心肌梗死患者。24例患者接受了链激酶(SK)静脉溶栓治疗,剂量为150万单位,经外周静脉给药。他们表现出以下再灌注迹象:疼痛缓解、ST段抬高迅速消退、再灌注相关心律失常和早期酶峰(CK-MB)。记录到7例死亡,其中6例未接受SK治疗。即使在没有血流动力学实验室的医院,溶栓治疗的使用也有助于降低死亡率。因此,这种治疗应在急性心肌梗死中尽早使用。